Kaplan-Meier estimate of PFS for patients with stage II bulky and stage III/IV cHL treated with ≤6 cycles of BV-N-AD with estimated PFS rate at 24 months, PFS events, and median follow-up for patients. Data cutoff: 22 May 2023. 95% CI, 95% confidence interval. See supplemental Figure 1 from the article by Lee et al that begins on page 290.

Kaplan-Meier estimate of PFS for patients with stage II bulky and stage III/IV cHL treated with ≤6 cycles of BV-N-AD with estimated PFS rate at 24 months, PFS events, and median follow-up for patients. Data cutoff: 22 May 2023. 95% CI, 95% confidence interval. See supplemental Figure 1 from the article by Lee et al that begins on page 290.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal